27 studies found for:    pkd
Show Display Options
Rank Status Study
1 Unknown  UAB Recessive PKD Research and Translational Core Center
Condition: Autosomal Recessive Polycystic Kidney Disease
Intervention:
2 Not yet recruiting LRRK2 Mutation and Parkinson's Disease
Condition: Parkinson Disease
Interventions: Genetic: Healthy;   Genetic: PKD Patients
3 Recruiting Pharmacogenomic Study on PKD/PKC of Dabigatran Etexilate and Rivaroxaban
Condition: Healthy Volunteers
Interventions: Drug: D->R->C+R;   Drug: D->R->C+D;   Drug: R->D->C+D;   Drug: R->D->C+R
4 Active, not recruiting HALT Progression of Polycystic Kidney Disease (HALT PKD)
Condition: Kidney, Polycystic
Interventions: Drug: Lisinopril and Placebo;   Drug: Lisinopril and Telmisartan
5 Recruiting Polycystic Kidney Disease Data Repository
Condition: Polycystic Kidney Disease
Intervention:
6 Recruiting Efficacy Study of Water Drinking on PKD Progression.
Conditions: Autosomal Dominant Polycystic Kidney Disease.;   Disease Progression
Intervention:
7 Unknown  High Water Intake to Slow Progression of Polycystic Kidney Disease
Condition: Kidney, Polycystic, Autosomal Dominant
Intervention: Other: Water
8 Completed Sirolimus Treatment in Patients With Autosomal Dominant Polycystic Kidney Disease: Renal Efficacy and Safety
Condition: Polycystic Kidney
Interventions: Drug: Sirolimus;   Drug: conventional therapy
9 Terminated Safety Study of SGX523, a Small Molecule Met Inhibitor, to Treat Solid Tumors
Condition: Advanced Cancer
Intervention: Drug: SGX523 Capsules
10 Completed Water as Therapy in Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Condition: Autosomal Dominant Polycystic Kidney Disease
Intervention: Other: Water prescription
11 Recruiting UAB HRFD Core Center: Core A: The Hepato/Renal Fibrocystic Diseases Translational Resource
Conditions: Hepato/Renal Fibrocystic Disease;   Autosomal Recessive Polycystic Kidney Disease;   Joubert Syndrome;   Bardet Biedl Syndrome;   Meckel-Gruber Syndrome;   Congenital Hepatic Fibrosis;   Caroli Syndrome;   Oro-Facial-Digital Syndrome Type I;   Nephronophthisis;   Glomerulocystic Kidney Disease
Intervention:
12 Recruiting A New Diet for Patients With Autosomal Dominant Polycystic Disease (ADPKD)
Condition: Autosomal Dominant Polycystic Kidney Disease
Intervention: Other: ADPKD Diet
13 Recruiting 8-Week Study of Tolvaptan Dose Forms in Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Condition: Autosomal Dominant Polycystic Kidney Disease
Interventions: Drug: Tolvaptan MR;   Drug: Tolvaptan IR;   Drug: Placebo
14 Unknown  Clinical Trial to Slow the Progression of ADPKD
Conditions: Kidney, Polycystic;   Kidney, Polycystic, Autosomal Dominant
Intervention: Drug: anti-hypertensive medications
15 Completed Pilot Study of RNA as a Biomarker for Autosomal Dominant Polycystic Kidney Disease
Conditions: Chronic Kidney Disease;   Polycystic Kidney, Autosomal Dominant
Intervention:
16 Active, not recruiting Personalized Diabetic Kidney Disease Risk Info to Initiate and Maintain Health Behavior Changes
Condition: Diabetic Kidney Disease
Intervention:
17 Terminated Pharmacokinetics, Pharmacodynamics and Safety Evaluation of SAR279356 in Intensive Care Unit Mechanically Ventilated Patients
Condition: Infection Prophylaxis
Interventions: Drug: SAR279356;   Drug: placebo
18 Completed Study of the Tolerability, Safety, Pharmacokinetics and Pharmacodynamics of SAR236553 (REGN727)
Condition: Hypercholesterolemia
Intervention: Drug: SAR236553/REGN727
19 Completed Single Dose Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Evaluation of Eplivanserin in Children With Insomnia
Condition: Sleep Initiation and Maintenance Disorders
Intervention: Drug: Eplivanserin (SR46349)
20 Completed Single Dose Study With a New Insulin Glargine Formulation and Lantus® in Japanese Patients With Type 1 Diabetes Mellitus
Condition: Type 1 Diabetes Mellitus
Interventions: Drug: Insulin glargine HOE901;   Drug: Insulin glargine - New formulation HOE901

Previous Page Studies Shown (1-20) Next Page (21-27) Show next page of results
Indicates status has not been verified in more than two years